IRIS
BOLIGNANO, DAVIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.256
AS - Asia 3.040
EU - Europa 1.223
SA - Sud America 683
Continente sconosciuto - Info sul continente non disponibili 280
AF - Africa 102
OC - Oceania 8
AN - Antartide 1
Totale 9.593
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.042
SG - Singapore 1.356
CN - Cina 661
IT - Italia 544
BR - Brasile 540
VN - Vietnam 317
IN - India 281
CA - Canada 151
SE - Svezia 145
DE - Germania 144
HK - Hong Kong 141
BD - Bangladesh 106
GB - Regno Unito 91
FI - Finlandia 63
AR - Argentina 55
NL - Olanda 43
MX - Messico 34
RU - Federazione Russa 28
ID - Indonesia 27
RO - Romania 27
EC - Ecuador 26
FR - Francia 26
ES - Italia 24
IQ - Iraq 22
PL - Polonia 22
ZA - Sudafrica 20
JP - Giappone 19
CL - Cile 18
UA - Ucraina 18
EG - Egitto 16
CO - Colombia 14
MA - Marocco 13
PK - Pakistan 13
TR - Turchia 13
IR - Iran 12
VE - Venezuela 11
AT - Austria 10
TN - Tunisia 10
UZ - Uzbekistan 9
KE - Kenya 8
PY - Paraguay 8
AU - Australia 7
JO - Giordania 7
PE - Perù 7
SA - Arabia Saudita 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
IL - Israele 6
SN - Senegal 6
TH - Thailandia 6
TW - Taiwan 6
NG - Nigeria 5
CR - Costa Rica 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LT - Lituania 4
MK - Macedonia 4
SC - Seychelles 4
AO - Angola 3
AZ - Azerbaigian 3
BB - Barbados 3
BG - Bulgaria 3
DK - Danimarca 3
GR - Grecia 3
HN - Honduras 3
JM - Giamaica 3
NI - Nicaragua 3
PA - Panama 3
SV - El Salvador 3
SY - Repubblica araba siriana 3
CH - Svizzera 2
EE - Estonia 2
ET - Etiopia 2
EU - Europa 2
GY - Guiana 2
HR - Croazia 2
KR - Corea 2
LB - Libano 2
ML - Mali 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PH - Filippine 2
PR - Porto Rico 2
SI - Slovenia 2
ZM - Zambia 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AQ - Antartide 1
AW - Aruba 1
BE - Belgio 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
Totale 9.303
Salva come PNG Salva come JPEG
Città #
San Jose 766
Singapore 472
Dallas 381
Ashburn 359
Santa Clara 283
Council Bluffs 263
Bengaluru 222
Hefei 222
Chandler 212
Milan 192
Lawrence 171
Princeton 171
Hong Kong 137
Beijing 123
Ho Chi Minh City 122
Wilmington 118
Ottawa 106
Munich 102
Los Angeles 63
Hanoi 59
São Paulo 56
Boardman 54
London 42
Des Moines 38
New York 38
Turku 38
Chicago 35
Rome 30
Phoenix 27
Helsinki 25
Naples 20
Rio de Janeiro 20
Boston 19
Warsaw 19
Amsterdam 17
Brooklyn 17
Mexico City 17
Da Nang 16
Orem 16
San Francisco 16
Tokyo 16
Chennai 15
The Dalles 15
Bari 14
Brasília 14
Catanzaro 13
Guayaquil 13
Montreal 13
Norwalk 13
Redmond 13
Columbus 12
Johannesburg 12
Biên Hòa 11
Haiphong 11
Timisoara 11
Crotone 10
Guangzhou 10
Guarulhos 10
New Delhi 10
Seattle 10
Stockholm 10
Atlanta 9
Jakarta 9
Manchester 9
Palermo 9
Pune 9
Baghdad 8
Charlotte 8
Florence 8
Hải Dương 8
Ninh Bình 8
Shibin al Kawm 8
Tashkent 8
Ankara 7
Erbil 7
Nairobi 7
Redwood City 7
Santo André 7
Shanghai 7
Thái Bình 7
Toronto 7
Washington 7
Ann Arbor 6
Asunción 6
Buenos Aires 6
Campinas 6
Catania 6
Cosenza 6
Dakar 6
Goiânia 6
Lima 6
Osasco 6
Quito 6
Salvador 6
São Bernardo do Campo 6
Tunis 6
Amman 5
Belo Horizonte 5
Bologna 5
Bình Dương 5
Totale 5.628
Salva come PNG Salva come JPEG
Nome #
Urinary Marinobufagenin in Patients with Non-Advanced Chronic Kidney Disease: A Cross-Sectional Study 129
Antecedent ACE-inhibition, inflammatory response, and cardiac surgery associated acute kidney injury 119
Hyperkalemia excursions and risk of mortality and hospitalizations in hemodialysis patients: results from DOPPS-Italy 114
Hypoxia-inducible factor stabilizers in end stage kidney disease: “can the promise be kept?” 89
Altered circulating marinobufagenin levels and recurrent intradialytic hypotensive episodes in chronic hemodialysis patients: a pilot, prospective study 88
#4500 IMPLEMENTATION OF A NEW GENERATION DIGITAL STETHOSCOPE FOR ARTERIOVENOUS FISTULA MONITORING IN HEMODIALYSIS PATIENTS 85
A Rare Complication of Ascariasis: A Case of Acute Interstitial Nephritis 84
A brief "update" on renal effects of caffeine 84
Exercise in Patients on Dialysis: A Multicenter, Randomized Clinical Trial. 80
Erratum: Exercise in patients on dialysis: A multicenter, randomized clinical trial (Journal of the American Society of Nephrology (2017) 28 (1259–1268) DOI: 10.1681/ASN.2016030378) 79
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients 78
A portable easy-to-use triboelectric sensor for arteriovenous fistula monitoring in dialysis patients 76
LOW CIRCULATING LEVELS OF CARDIO-REGULATORY MIRNAS PREDICT WORSE OUTCOMES IN HEMODIALYSIS PATIENTS 74
Evaluation of arteriovenous fistula for hemodialysis with a new generation digital stethoscope: a pilot study 73
Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease 73
Acquisition of optical coherence tomography angiography metrics during hemodialysis procedures: A pilot study 70
Renal denervation for resistant hypertension 70
[AVP: a new target in the treatment of chronic kidney disease?] 70
Circulating Omentin-1 levels and altered iron balance in chronic haemodialysis patients 69
Role of Vitamin K in Chronic Kidney Disease: A Focus on Bone and Cardiovascular Health 68
A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients 67
Hyperkalemia in CKD: an overview of available therapeutic strategies 67
The Mitochondrial-Derived Peptide MOTS-c May Refine Mortality and Cardiovascular Risk Prediction in Chronic Hemodialysis Patients: A Multicenter Cohort Study 66
Autosomic dominant polycystic kidney disease and metformin: Old knowledge and new insights on retarding progression of chronic kidney disease 66
#4524 TRIBOELECTRIC EVALUATION OF ARTERIOVENOUS FISTULA FOR HAEMODIALYSIS: A PILOT STUDY 65
Anemia and Mineral Bone Disorder in Kidney Disease Patients: The Role of FGF-23 and Other Related Factors 65
MOTS-c Levels and Sarcopenia Risk in Chronic Peritoneal Dialysis Patients: A Pilot Study 63
Aldosterone antagonists for preventing the progression of chronic kidney disease 63
Alterations of lipid metabolism in chronic nephropathies: Mechanisms, diagnosis and treatment 62
[Neutrophil gelatinase-associated lipocalin (NGAL): a biomarker beyond the confines of nephrology] 62
New Insights on the Role of Marinobufagenin from Bench to Bedside in Cardiovascular and Kidney Diseases 61
Effects of weight loss on renal function in obese CKD patients: A systematic review 61
Levels of neutrophil gelatinase-associated lipocalin in 2 patients with crush syndrome after a mudslide 61
A case-by-case protocol of membranous nephropathy treatment with endovenous infusion of high doses of human immunoglobulins 60
Blood pressure monitoring in kidney transplantation: a systematic review on hypertension and target organ damage 59
Development of a Wearable Device for Arteriovenous Fistula Monitoring 59
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases 59
Nephrosclerosis impacts time trajectory of renal function and outcomes in elderly individuals with chronic kidney disease 59
Retarding progression of chronic kidney disease in autosomal dominant polycystic kidney disease with metformin and other therapies: An update of new insights 58
Circulating Omentin-1, Sustained Inflammation and Hyperphosphatemia at the Interface of Subclinical Atherosclerosis in Chronic Kidney Disease Patients on Chronic Renal Replacement Therapy 58
Very low urinary marinobufagenin excretion reflects a high risk of disease progression in non-advanced CKD 56
Erythropoietin and its lost receptor 56
[Italian adaptation of the European Renal Best Practice (ERBP) guideline on kidney donor and recipient evaluation and perioperative care] 56
P1422CATHEPSIN-K IS A POWERFUL DIAGNOSTIC BIOMARKER IN PARATHYROIDECTOMIZED DIALYSIS PATIENTS 56
Marinobufagenin, left ventricular geometry and cardiac dysfunction in end-stage kidney disease patients 56
Aquaretic agents: What's beyond the treatment of hyponatremia? 55
Biomarkers of cardio-renal damage in chronic kidney disease: one size cannot fit all 55
Increased circulating Cathepsin-K levels reflect PTH control in chronic hemodialysis patients 54
Arrhythmias and hemodialysis: role of potassium and new diagnostic tools 53
Aquaretic-induced apoptosis: A cure or a curse? 53
P1417ALTERED CATHEPSIN-K LEVELS REFLECT SEVERITY OF MINERAL BONE DISEASE AND INFLAMMATION IN CHRONIC HEMODIALYSIS PATIENTS 53
Acute cardiovascular complications of hemodialysis 52
Glitazones in chronic kidney disease: Potential and concerns 52
OCT angiography metrics predict intradialytic hypotension episodes in chronic hemodialysis patients: a pilot, prospective study 52
Childhood Obesity: Insight into Kidney Involvement 51
Selenoprotein P-1 (SEPP1) as an Early Biomarker of Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass 51
Aquaporin-2 (AQP2) urinary excretion and assumption of water with different mineral content in healthy subjects 51
Understanding Vascular Calcification in Chronic Kidney Disease: Pathogenesis and Therapeutic Implications 50
Dialysis and the Elderly: An Underestimated Problem 50
Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis 50
Study designs adopted in epidemiology of chronic diseases 50
Potential Pathogenetic Role of the D313Y Mutation in the GLA Gene in Anderson Fabry Disease: Two Case Reports 49
Immunosuppressive Therapy, Puberty and Growth Outcomes in Pediatric Kidney Transplant Recipients: A Pragmatic Review 49
Parathyroid hormone and mobilization of circulating bone marrow-derived cells in uremic patients. 49
Physical performance and clinical outcomes in dialysis patients: a secondary analysis of the EXCITE trial 49
Biotic Supplements for Renal Patients: A Systematic Review and Meta-Analysis 49
[The future of the European nephrology belongs to the young: the Young Nephrologists' Platform] 49
Unraveling Cardiovascular Risk in Renal Patients: A New Take on Old Tale 49
Urinary Post-Translationally Modified Fetuin-A (uPTM-FetA) in Chronic Kidney Disease Patients with and without Diabetic Kidney Disease 48
Perioperative iloprost and endothelial progenitor cells in uremic patients with severe limb ischemia undergoing peripheral revascularization 48
Genomic damage in endothelial progenitor cells from uremic patients 48
[Erythropoietin: pleiotropic actions] 48
Utility of Blood Flow/Resistance Index Ratio (Qx) as a Marker of Stenosis and Future Thrombotic Events in Native Arteriovenous Fistulas 48
Oxidative stress and kidney function: a brief update 47
Malnutrition in the elderly patient on dialysis 46
Circulating progenitor cells after cold pressor test in hypertensive and uremic patients 46
Caffeine and the kidney: What evidence right now? 46
Neutrophil Gelatinase-associated Lipocalin in the Cardio–Renal Axis – Pathogenic Factor or Just a Risk Biomarker? 46
Study designs adopted in epidemiology of chronic diseases 46
Anti-seizure medications in patients with renal failure undergoing dialysis: how to manage? 46
Decreased Cathepsin-K Mirrors the Severity of Subclinical Atherosclerosis in Kidney Transplant Recipients 45
Fitness for entering a simple exercise program and mortality: a study corollary to the exercise introduction to enhance performance in dialysis (EXCITE) trial. 45
Physical excercise programs in CKD: lights, shades and perspectives: a position paper of the “Physical Exercise in CKD Study Group” of the Italian Society of Nephrology 45
Good-quality research in rare diseases: trials and tribulations 45
The aging kidney revisited: A systematic review 45
Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) Predicts Renal Function Decline in Patients With Glomerular Diseases 45
Osteoprotegerin and carotid atherosclerosis in dialysis patients: An imaging (ECO-Doppler) and genic expression study 44
Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients 44
Baroreflex stimulation for treating resistant hypertension: Ready for the prime-time? 44
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage 44
Smoking habit as a risk amplifier in chronic kidney disease patients 44
Circulating miRNA 122-5p Expression Predicts Mortality and Cardiovascular Events in Chronic Hemodialysis Patients: A Multicentric, Pilot, Prospective Study 43
Neurobiological model and quality of life in discovering personality of the uremic patient 43
Circulating endothelial progenitor cell mobilization in centenarians: a powerful source for extended renal life 43
Aquaretic inhibits renal cancer proliferation: Role of vasopressin receptor-2 (V2-R) 43
[TNF-alpha receptors (TNFRS): the biomarkers of progressive diabetic nephropathy we were waiting for?] 43
Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis 43
Hypertension in kidney transplantation: a consensus statement of the 'hypertension and the kidney' working group of the European Society of Hypertension 42
Effect of immunoglobulin treatment on endothelial progenitor cells in systemic lupus erythematosus 42
Both IL-1β and TNF-α regulate NGAL expression in polymorphonuclear granulocytes of chronic hemodialysis patients 42
Totale 5.805
Salva come PNG Salva come JPEG
Categoria #
all - tutte 101.357
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.357
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022435 0 1 3 86 59 5 18 120 29 25 85 4
2022/2023869 344 99 17 38 54 43 13 55 100 28 57 21
2023/2024533 74 41 43 39 42 89 25 47 25 45 28 35
2024/20252.115 312 70 54 132 145 349 49 63 240 62 231 408
2025/20264.974 252 582 627 775 480 167 514 248 666 384 218 61
2026/2027288 51 237 0 0 0 0 0 0 0 0 0 0
Totale 9.593